Milestone Pharmaceuticals (MIST) vs Rallybio (RLYB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rallybio (RLYB) has outperformed Milestone Pharmaceuticals (MIST) over the past year, gaining 277.9% versus a loss of 63.6%. Over five years, RLYB leads with a -86.4% price change compared with -87.2% for MIST. Rallybio is the larger company by market cap ($89.6 million vs $88.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIST | RLYB |
|---|---|---|
| Share price | $0.7119 | $16.87 |
| Market cap | $88.63M | $89.62M |
| 1-day change | -5.98% | -0.35% |
| YTD return | -62.51% | +208.49% |
| 1-year return | -63.60% | +277.90% |
| 5-year return | -87.17% | -86.36% |
| P/E ratio (TTM) | — | 2.11 |
| EPS (TTM) | $-0.68 | $8.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.06 | $17.57 |
| 52-week low | $0.7098 | $3.67 |
| Distance from 52-week high | -76.74% | -4.01% |
| Average volume | 1.39M | 22.16K |
| Shares outstanding | 124.50M | 5.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RLYB has outperformed MIST by 341.5 percentage points over the past year.
MIST vs RLYB FAQ
Which is bigger, Milestone Pharmaceuticals or Rallybio?
Rallybio (RLYB) is larger, with a market capitalization of $89.62M compared with $88.63M for Milestone Pharmaceuticals (MIST).
Which stock has performed better over the past year, MIST or RLYB?
RLYB returned +277.90% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Pharmaceuticals and Rallybio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.